N. W. Albrechtsen

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Nicolai Jacob Wewer Albrechtsen, N Wewer Albrechtsen, Nicolai J.wewer Albrechtsen, N. J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen, Nicolai J. W. Albrechtsen, Nicolai J W Albrechtsen, Nicolai J Wewer Albrechtsen, Nicolai Wewer Albrechtsen
Publication record
65 papers · 1,439 citations · H-index 17

PAPERS

In vivo inhibition of dipeptidyl peptidase 4 allows measurement of GLP-1 secretion in mice.
202413 citationsauthor #4
Foresight in clinical proteomics: current status, ethical considerations, and future perspectives
202314 citationsauthor #2
Inhibition of dipeptidyl peptidase 4 allows accurate measurement of GLP-1 secretion in mice
20231 citationsauthor #4
Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells
20235 citationsauthor #5
Studies to develop a glucagon sensitivity test in humans: The GLUSENTIC study protocol
20220 citationsauthor #21
A knowledge graph to interpret clinical proteomics data
2022207 citationsauthor #8
1385-P: Impact of Preanalytical and Analytical Factors on Glucagon and GLP-1 Levels in Humans
20220 citationsauthor #7
Dynamic human liver proteome atlas reveals functional insights into disease pathways
202243 citationsauthor #7
1192-P: Robust Arginine-Stimulated Glucagon Secretion in Patients with Type 1 Diabetes Independent of Diabetes Duration, Age, HbA1c, and Beta-Cell Secretory Capacity
20210 citationsauthor #5
216-LB: Development and Evaluation of a Glucagon Sensitivity Test in Humans
20210 citationsauthor #15
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
202136 citationsauthor #5
Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
202125 citationsauthor #16
On Premises and Principles for Measurement of Gastrointestinal Peptide Hormones.
20216 citationsauthor #1
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
202157 citationsauthor #6
154-OR: Neprilysin Inhibition Increases Glucagon Levels with Possible Implications for Hepatic Amino Acid Metabolism
20200 citationsauthor #16
Proglucagon peptide secretion post Roux-en-Y gastric bypass: one year prospective study
20201 citationsauthor #4
Review for "Differential effects of L‐ and D‐phenylalanine on pancreatic and gastrointestinal hormone release in humans: a randomised crossover study"
20200 citationsauthor #1
355-OR: Effects of a Six-Week Intervention with Glucagon-Like Peptide-1 Analogue on Pancreatic Volume, Edema, and DNA Synthesis in Obese Men
20200 citationsauthor #16
Plasma proteome profiles treatment efficacy of incretin dual agonism in diet‐induced obese female and male mice
202018 citationsauthor #12
Author response for "No effects of a six‐week intervention with glucagon‐like peptide‐1 receptor analogue on pancreatic volume and edema in obese men without diabetes"
20200 citationsauthor #16
298-OR: Disruption of Multiple Cell-Autonomous Protein Phosphorylation Networks Underlies Muscle Insulin Resistance in Type 2 Diabetes
20200 citationsauthor #2
Clinical Knowledge Graph Integrates Proteomics Data into Clinical Decision-Making
202053 citationsauthor #7
1908-P: Glucagon Receptor Expression Evaluated by Antibody-Dependent and -Independent Approaches
20201 citationsauthor #11
220-LB: Glucagon Promotes Hepatic Autophagy by AMPK-Mediated mTORC1 Inhibition
20202 citationsauthor #2
936-P: Plasma Proteomic Profiling Delineates Treatment Efficacy of a GLP-1/GIP Coagonist in Female and Male Mice
20200 citationsauthor #2
844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial
20200 citationsauthor #10
77-OR: The Gut Peptide Neurotensin Does Not Reduce Appetite and Food Intake in Healthy Young Men
20200 citationsauthor #8
Glucose homeostasis and the gastrointestinal tract
20193 citationsauthor #2
Neuromedin U Does Not Act as a Decretin in Rats
201910 citationsauthor #13
Proglucagon peptide family responses after RYGB surgery in obese patients with type 2 diabetes
20190 citationsauthor #7
62-OR: Evidence of Gut-Derived Glucagon in Man
20191 citationsauthor #3
63-OR: The Physiological Effects of Extrapancreatic Glucagon in Totally Pancreatectomized Patients Evaluated Using Glucagon Receptor Antagonism
20190 citationsauthor #4
1952-P: Glucagon Receptor Antagonism Increases Plasma Amino Acids and Glucagon
20193 citationsauthor #2
Universitet Glucagon Receptor Signaling and Lipid Metabolism
20190 citationsauthor #5
Plasma proteome profiling discovers potential biomarkers of non-alcoholic fatty liver disease
20190 citationsauthor #4
Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study.
20193 citationsauthor #6
Review for "Role of apolipoprotein C‐III overproduction in diabetic dyslipidemia"
20190 citationsauthor #1
57-OR: Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Glycaemia and Body Weight in Obesity and Type 2 Diabetes: A Randomized, Single-Blinded Study
20192 citationsauthor #5
1002-P: Sacubitril/Valsartan Increases Postprandial Glucagon-Like Peptide-1 Concentrations and Has Synergistic Effects when Combined with Sitagliptin
20191 citationsauthor #1
Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications.
201951 citationsauthor #2
1966-P: Manipulating Postprandial Bile Acid Concentrations: Effect on GLP-1 Secretion after Roux-en-Y Gastric Bypass
20190 citationsauthor #5
Amino Acid Metabolism Is Regulated by Glucagon Receptor Signaling in Mice
20184 citationsauthor #5
Oxyntomodulin: Actions and role in diabetes
201878 citationsauthor #2
Glucagon Resistance at the Level of Amino Acid Turnover and Ureagenesis in Obese Subjects with Hepatic Steatosis
20182 citationsauthor #4
WITHDRAWN: Glucagon Processing
20180 citationsauthor #2
Insulin and Glucagon Interaction Studied by Separate and Combined Receptor Antagonism
20180 citationsauthor #4
The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
201787 citationsauthor #6
Integrated Physiology/Obesity
20170 citationsauthor #3
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
201730 citationsauthor #3
Measurement of Gastrointestinal Hormones.
20178 citationsauthor #1
Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery
2016161 citationsauthor #8
GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
201511 citationsauthor #6
A novel immune-based approach for measurement of the anorectic gut hormone oxyntomodulin: changes after gastric bypass surgery
20153 citationsauthor #1
Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides
20150 citationsauthor #2
An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine.
2015145 citationsauthor #3
Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides
201513 citationsauthor #2
GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines.
201454 citationsauthor #2
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.
2014123 citationsauthor #2
No Effect of Aprotinin (Trasylol™) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma
20148 citationsauthor #2
Specificity and sensitivity of commercially available assays for glucagon‐like peptide‐1 (GLP‐1): implications for GLP‐1 measurements in clinical studies
2014108 citationsauthor #2
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
201429 citationsauthor #1
oxyntomodulin measurement in human 2
20140 citationsauthor #2
SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
20131 citationsauthor #1
The effect of gastric bypass treatment for obesity on hormones related to bone re-modeling and intestinal growth
20131 citationsauthor #5
Gangliocytic paraganglioma of duodenum metastatic to lymph nodes and liver and extending into the retropancreatic space.
201322 citationsauthor #2

TIMELINE

2013 24 citations

2014 322 citations

2015 172 citations

2016 161 citations

2017 125 citations

2018 84 citations

2019 74 citations

2020 75 citations

2021 124 citations

2022 250 citations

2023 20 citations

2024 13 citations

N. W. Albrechtsen

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT